Evidence-based, personalized medicine unlocks the power of the patient genome and allows you to deliver more –and better– insights into disease treatment and and risk stratification.
Cytogenetic anomaly detection provides you with diagnostic and prognostic information, as well as risk stratification, for better patient management, treatment decisions, and response monitoring.
A wealth of phenotypic information about complex hematopoietic malignancies and disorders is delivered by ten-color flow interrogation with minimal specimen requirements and lower costs.
Expert morphologists provide a thorough understanding of the subtleties of cell architecture and pattern recognition through an extensive suite of immunohistochemical and special stains.
HEREDITARY CANCER RISK
Get all the answers you need.
There's no rush. We're committed to giving you as much consultation time as necessary to help your patients.
"siParadigm has worked with us tirelessly to accommodate our specific needs. Their competence and flexibility place them far ahead of any other competitor."
Miguel Sanchez, MD, PhD
Chief of Pathology, Englewood Hospital
service. integrity. Paradigm.
We grow and adapt to consistently meet the needs of patients, physicians, and healthcare providers.
"My expectations are constantly exceeded by the turnaround time, personalized service, and collaborative approach to reach the correct diagnosis."
Desiree A. Carlson, MD
Chief of Pathology, Signature Healthcare
Securely order tests online and view diagnostic results directly on your phone, tablet, or desktop.
A Model Experience
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
Accredited and Certified
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.